530 related articles for article (PubMed ID: 22348694)
21. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial.
López NJ; Quintero A; Casanova PA; Ibieta CI; Baelum V; López R
J Periodontol; 2012 Mar; 83(3):267-78. PubMed ID: 21749167
[TBL] [Abstract][Full Text] [Related]
22. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
[TBL] [Abstract][Full Text] [Related]
23. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
24. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
[TBL] [Abstract][Full Text] [Related]
25. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
[TBL] [Abstract][Full Text] [Related]
26. Elevated visfatin levels in obese children are related to proinflammatory factors.
Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
[TBL] [Abstract][Full Text] [Related]
27. Significance of leptin and high-molecular weight adiponectin in the general population of Japanese male adolescents.
Nakatani H; Hirose H; Yamamoto Y; Saito I; Itoh H
Metabolism; 2008 Feb; 57(2):157-62. PubMed ID: 18191043
[TBL] [Abstract][Full Text] [Related]
28. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
29. A study to evaluate the relationship between periodontitis, cardiovascular disease and serum lipid levels.
Sridhar R; Byakod G; Pudakalkatti P; Patil R
Int J Dent Hyg; 2009 May; 7(2):144-50. PubMed ID: 19413548
[TBL] [Abstract][Full Text] [Related]
30. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
[TBL] [Abstract][Full Text] [Related]
31. Periodontal status and hyperlipidemia: statin users versus non-users.
Sangwan A; Tewari S; Singh H; Sharma RK; Narula SC
J Periodontol; 2013 Jan; 84(1):3-12. PubMed ID: 22468682
[TBL] [Abstract][Full Text] [Related]
32. Assessment of high-sensitivity C-reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis--a cross-sectional study.
Kumar KR; Ranganath V; Naik R; Banu S; Nichani AS
J Periodontal Res; 2014 Dec; 49(6):836-44. PubMed ID: 24620793
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects.
Zhang Y; Han P; Wu N; He B; Lu Y; Li S; Liu Y; Zhao S; Liu L; Li Y
Obesity (Silver Spring); 2011 Aug; 19(8):1647-53. PubMed ID: 21593803
[TBL] [Abstract][Full Text] [Related]
34. Response to periodontal therapy in patients who had weight loss after bariatric surgery and obese counterparts: a pilot study.
Lakkis D; Bissada NF; Saber A; Khaitan L; Palomo L; Narendran S; Al-Zahrani MS
J Periodontol; 2012 Jun; 83(6):684-9. PubMed ID: 22014172
[TBL] [Abstract][Full Text] [Related]
35. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
[TBL] [Abstract][Full Text] [Related]
36. Daidzein improves insulin resistance in ovariectomized rats.
Cao YK; Zhang SF; Zou SE; Xia X
Climacteric; 2013 Feb; 16(1):111-6. PubMed ID: 22607577
[TBL] [Abstract][Full Text] [Related]
37. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used.
Marques-Vidal P; Velho S; Waterworth D; Waeber G; von Känel R; Vollenweider P
Eur J Clin Nutr; 2012 Apr; 66(4):426-35. PubMed ID: 21952696
[TBL] [Abstract][Full Text] [Related]
38. Effects of nonsurgical periodontal therapy on C-reactive protein and serum lipids in Jordanian adults with advanced periodontitis.
Kamil W; Al Habashneh R; Khader Y; Al Bayati L; Taani D
J Periodontal Res; 2011 Oct; 46(5):616-21. PubMed ID: 21631509
[TBL] [Abstract][Full Text] [Related]
39. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children.
Reinehr T; Stoffel-Wagner B; Roth CL; Andler W
Metabolism; 2005 Sep; 54(9):1155-61. PubMed ID: 16125526
[TBL] [Abstract][Full Text] [Related]
40. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
